6.30.26
Real-world chronic recordings from implantable adaptive deep brain stimulation systems for Parkinson's disease motor state classification
8.28.25
Cognitive effects of adaptive deep brain stimulation in Parkinson's disease: stability without risk
5.5.25
Will adaptive deep brain stimulation for Parkinson's disease become a real option soon? A Delphi consensus study
10.28.24
Can total electrical energy (TEED) after subthalamic DBS alter verbal fluency in Parkinson's disease patients? A preliminary evidence
10.25.24
Adaptive vs. Conventional Deep Brain Stimulation: One-Year Subthalamic Recordings and Clinical Monitoring in a Patient with Parkinsonâs Disease
3.7.24
Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: Pushing the Forefront of Neuromodulation with Functional Network Mapping, Biomarkers for Adaptive DBS, Bioethical Dilemmas, AI-Guided Neuromodulation, and Translational Advancements
2.23.23
Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation
7.15.22
Advances in DBS Technology and Novel Applications: Focus on Movement Disorders
1.4.22
Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinsonâs disease
12.24.21
A New Implantable Closed-Loop Clinical Neural Interface: First Application in Parkinsonâs Disease
10.22.21
Deep brain stimulation: is it time to change gears by closing the loop?
9.29.21
Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinsonâs disease
8.9.21
Clinical perspectives of adaptive deep brain stimulation
3.21.19
Monitoring Subthalamic Oscillations for 24 Hours in a Freely Moving Parkinsonâs Disease Patient
2.18.18
Eight-hours adaptive deep brain stimulation in patients with Parkinson disease
1.4.18
Adaptive Deep Brain Stimulation (aDBS) for Tourette Syndrome
2.18.17
Adaptive Deep Brain Stimulation Controls Levodopa-Induced Side Effects in Parkinsonian Patients
9.11.14
WebBioBank: a new platform for integrating clinical forms and shared neurosignal analyses to support multi-centre studies in Parkinson's Disease
Partner with Newronika to bring the next generation of adaptive brain therapy to patients who need it most.
Whether youâre a clinician, researcher, investor, or partner â weâd love to hear from you.